13 research outputs found
Dietary Supplementation With Tinospora cordifolia Improves Anxiety-Type Behavior and Cognitive Impairments in Middle-Aged Acyclic Female Rats
The midlife transition period in women marks the progressive flattening of neurological health along with increased adiposity, dyslipidemia, frailty, and inflammatory responses mainly attributed to the gradual decline in estrogen levels. Conflicting reports of hormone replacement therapy (HRT) necessitate the exploration of novel therapeutic interventions using bioactive natural products having the least toxicity and a holistic mode of action for the preservation of metabolic homeodynamics with aging in women. The present study was planned to investigate the effects of aging and/or a high-fat diet (HFD) on cognitive impairments and anxiety and further their management by dietary supplement with the Tinospora cordifolia stem powder (TCP). Acyclic female rats were included in this study as the model system of the perimenopause phase of women along with young 3–4 months old rats as controls. Rats were fed on with and without TCP supplemented normal chow or HFD for 12 weeks. Animals fed on a TCP supplemented normal chow showed consistent management of body weight over a 12-week regimen although their calorie intake was much higher in comparison to their age-matched controls. Post-regimen, neurobehavioral tests, such as novel object recognition and elevated plus maze, performed on these animals showed improvement in their learning and memory abilities as well as the anxiety-like behavior. Furthermore, due to the presence of multiple components, TCP was observed to modulate the expression of key marker proteins to ameliorate neuroinflammation and apoptosis and promote cell survival and synaptic plasticity in the hippocampus and the prefrontal cortex (PFC) regions of the brain. These findings suggest that TCP supplementation in diet during the midlife transition period in women may be a potential interventional strategy for the management of menopause-associated anxiety and cognitive impairments and healthy aging
Altered glucose homeostasis in response to aluminium phosphide induced cellular oxygen deficit in rat
722-730The present
study was designed to analyze the effect of acute aluminium phosphide (ALP) (10
mg/kg body wt.) exposure on the glucose homeostasis in rat liver and brain. ALP
has been implicated in the inhibition of cytochrome oxidase causing reduced
oxygen uptake and decreased ATP synthesis eventually resulting in cellular
energy crisis. A significant decrease in plasma glucose levels in the ALP
treated rats has been observed. Therefore, decreased ATP levels coupled with
hypoglycemia may further intensify the cellular energy deficits. In order to
meet the sudden increase in the local energy demand, the brain tissue utilizes
its stored energy in the form of glycogen breakdown as observed by a decrease in
the glycogen levels in both liver and brain which was accompanied by a marked
increase in the activity of glycogen phosphorylase in both the tissues. The
glycolytic rate was found to be enhanced in brain tissue as evident by
increased activities of hexokinase and phosphofructokinase enzymes, but
decreased in liver of ALP treated rats. Lactate levels were increased in plasma
and brain, but decreased in liver of ALP treated rats. Pyruvate levels
increased in the plasma and liver, but no change was observed in the brain
tissue. ALP did not cause any change in the gluconeogenic enzymes like
glucose-6-phosphatase and fructose-1,6-bisphophatase in brain, but a
significant increase was observed in the liver. Results of the study showed
that ALP induced cellular energy deficit leads to compromised energy status of
liver and brain coupled with substantial alterations in glucose homeostasis.
However, the activity of glucose-6-phosphate dehydrogenase decreased
significantly in both the tissues
Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain
Dichlorvos is a synthetic insecticide that belongs to the family of chemically related organophosphate(OP) pesticides. It can be released into the environment as a major degradation product of other OPs, such as trichlorfon, naled, and metrifonate. Dichlorvos exerts its toxic effects in humans and animals by inhibiting neural acetylcholinesterase. Chronic low-level exposure to dichlorvos has been shown to result in inhibition of the mitochondrial complex I and cytochrome oxidase in rat brain, resulting in generation of reactive oxygen species (ROS). Enhanced ROS production leads to disruption of cellular antioxidant defense systems and release of cytochrome c (cyt c) from mitochondria to cytosol resulting in apoptotic cell death. MitoQ is an antioxidant, selectively targeted to mitochondria and protects it from oxidative damage and has been shown to decrease mitochondrial damage in various animal models of oxidative
stress. We hypothesized that if oxidative damage to mitochondria does play a significant role in dichlorvos induced neurodegeneration, then MitoQ should ameliorate neuronal apoptosis. Administration of MitoQ (100 mmol/kg body wt/day) reduced dichlorvos (6 mg/kg body wt/day) induced oxidative stress (decreased ROS production, increased MnSOD activity and glutathione levels) with decreased lipid peroxidation, protein and DNA oxidation. In addition, MitoQ also suppressed DNA fragmentation, cyt c
release and caspase-3 activity in dichlorvos treated rats compared to the control group. Further electron
microscopic studies revealed that MitoQ attenuates dichlorvos induced mitochondrial swelling, loss of
cristae and chromatin condensation. These results indicate that MitoQ may be beneficial against OP (dichlorvos) induced neurodegeneration